Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy

NCT03493789 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Stage I Lung Cancer
Stage I Non-Small Cell Lung Cancer AJCC v7
Stage IA Non-Small Cell Lung Carcinoma AJCC v7
Stage IB Non-Small Cell Lung Carcinoma AJCC v7
Stage II Lung Cancer
Stage II Non-Small Cell Lung Cancer AJCC v7
Stage IIA Non-Small Cell Lung Carcinoma AJCC v7
Stage IIB Non-Small Cell Lung Carcinoma AJCC v7

Interventions

DRUG: Fludeoxyglucose F-18
PROCEDURE: Positron Emission Tomography (PET)
RADIATION: Stereotactic Body Radiation Therapy (SBRT)

Sponsor

Emory University

Collaborators

[object Object]
[object Object]
[object Object]